Tag: GlobeNewswire

CALGARY, Alberta, Oct. 29, 2026 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) announces that the Company will release its 2026 third quarter financial and operating results on Thursday, November 5, 2026, post-market. Gran Tierra will host its third quarter 2026 results conference call on Friday, November 6, 2026, at 9:00 a.m. Alberta Time, 10:00 a.m. Eastern Time, and 3:00 p.m. Greenwich Mean Time.

How to Participate in the 2026 Third Quarter Conference Call

Interested parties may register for the 2026 third quarter conference call by clicking on this link. Please note that there is no longer a general dial-in number to participate, and each individual party must register through the provided link. Once parties have registered, they will be provided a unique PIN and call-in details. There is also a feature that allows parties to elect to be called back through the “Call Me” function on the platform.

Interested parties can also continue to access the live webcast from their mobile or desktop devices by clicking on this link, which is also available on Gran Tierra’s website at https://www.grantierra.com/investor-relations/presentations-events/. An audio replay of the conference call will be available at the same webcast link two hours following the call and will be available until November 6, 2027.

Contact Information

For investor and media inquiries please contact:

Gary Guidry
President and Chief Executive Officer

Ryan Ellson
Executive Vice President and Chief Financial Officer

Tel: (403) 265-3221

info@grantierra.com

About Gran Tierra Energy Inc.

Gran Tierra Energy Inc., together with its subsidiaries, is an independent international energy company currently focused on oil and natural gas exploration and production in Canada, Colombia and Ecuador. The Company is the operator of, and holds a 65% working interest in, an onshore exploration, development and production sharing agreement in Azerbaijan. Upon completion of the previously announced sale of its Colombian and Ecuadorian businesses (the “Sale”), the Company’s operations will be focused on Canada and Azerbaijan, and the Company will continue to pursue additional new growth opportunities that would further strengthen the Company’s portfolio.  The Company’s common stock trades on the NYSE American, the Toronto Stock Exchange and the London Stock Exchange under the ticker symbol GTE. Additional information concerning Gran Tierra is available at www.grantierra.com. Except to the extent expressly stated otherwise, information on the Company’s website or accessible from our website or any other website is not incorporated by reference into and should not be considered part of this press release. Investor inquiries may be directed to info@grantierra.com or (403) 265-3221.

Gran Tierra’s filings with the U.S. Securities and Exchange Commission (the “SEC”) are available on the SEC website at https://www.sec.gov. Gran Tierra’s Canadian securities regulatory filings are available on SEDAR+ at https://www.sedarplus.ca and UK regulatory filings are available on the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

HOUSTON, Oct. 29, 2026 (GLOBE NEWSWIRE) — Evolution Petroleum Corporation (NYSE American: EPM) (“Evolution” or the “Company”) today announced that it plans to release its fiscal first quarter 2027 financial and operating results on Tuesday, November 10, 2026, after the market closes. Additionally, Kelly Loyd, President and Chief Executive Officer, Ryan Stash, Senior Vice President, Chief Financial Officer, and Treasurer, and Mark Bunch, Senior Vice President and Chief Operating Officer, will review the results on a conference call at 10:00 a.m. Central Time on Wednesday, November 11, 2026.

Conference Call and Webcast Details
Date: Wednesday, November 11, 2026
Time: 10:00 a.m. Central Time
US/Toll-Free Dial-in: (844) 481-2813 | International Dial-in: (412) 317-0677
Note: Dial-in participants should ask to join the Evolution Petroleum Corporation call.
Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=uYSuksKF
A webcast replay will be available through November 10, 2027, via the webcast link above and on Evolution’s website at www.ir.evolutionpetroleum.com.

About Evolution Petroleum

Evolution Petroleum Corporation is an independent energy company focused on maximizing total shareholder returns through the ownership of and investment in onshore oil and natural gas properties in the U.S. The Company aims to build and maintain a diversified portfolio of long-life oil and natural gas properties through acquisitions, selective development opportunities, production enhancements, and other exploitation efforts. Visit www.evolutionpetroleum.com for more information.

Contact

Investor Relations
(713) 935-0122
ir@evolutionpetroleum.com

SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming UBS Global Healthcare Conference in Palm Beach Gardens, FL. Management will be hosting a fireside chat on Tuesday, November 10, 2026, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by registering at this link SI-BONE, Inc. – 1781346. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone. With expertise in biomechanical design and anatomy specific innovation, SI-BONE has built a technology platform with market-leading applications centered on the spinopelvic anatomy. SI-BONE continues to leverage the deep experience in addressing the challenges of low-density bone in the sacrum to develop unique technologies that are targeting new clinical adjacencies to help improve outcomes for patients with compromised bone. Since 2009, SI-BONE has supported physicians in performing over 150,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including four randomized controlled trials and over 190 peer reviewed publications.

For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.

SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved.

Investor Contact: Saqib Iqbal investors@si-bone.com 

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS

TORONTO, Oct. 29, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announced that it has closed a non-brokered private placement (“Offering”) of 2,000 non-convertible debenture units of the Company (“Units”) at a price of $1,000 per Unit for aggregate gross proceeds of approximately $2,000,000. Each Unit consists of an aggregate of $1,000 principal amount of unsecured non-convertible debentures (“Debentures”) and 2,000 common share purchase warrants (each, a “Warrant”). The Debentures will mature one year following the closing of the Offering (“Maturity Date”).

“We have made progress, and continue to make progress, in developing, commercializing and optimizing our diversified portfolio of products through various platforms and business units. This financing provides additional working capital and financial flexibility to support our continued growth, strengthening our domestic and international commercial and operational endeavors, and expanding our roadmap for the future, while at the same time maintaining our focus on operational efficiencies and disciplined capital allocation” stated Aras Azadian, CEO of Avicanna.

The Debentures will bear interest at a rate of 13% per annum, payable monthly. Company paid each subscriber a one-time administrative fee equal to 2% of the aggregate principal amount of the Debentures subscribed for. Each Warrant is exercisable into one common share in the capital of the Company (each a “Warrant Share”) at a price of $0.20 per share for a period of three years from the closing of the Offering. The Company shall have the right at any time and from time to time during the period commencing on the date that is six months from the closing of the Offering and the Maturity Date, to repay up to 100% of the principal amount of the then outstanding Debentures. The Debentures will rank pari passu in right of payment of principal with all other Debentures issued under the Offering. The Debentures will initially be unsecured obligations of the Company, and the Company has agreed to enter into a general security agreement with the holders of Debentures, granting a security interest to secure the obligations of the Company under the Debentures, on or before the date that is one month following the closing of the Offering. The Company intends to use the proceeds from the Offering for general working capital purposes, general and administrative expenses, expenditures related to production and manufacturing, and research and clinical development.

All securities issued under the Offering, including securities issuable on exercise thereof, are subject to a hold period expiring on March 1, 2027.

The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Toronto Stock Exchange (the “TSX”).

About Avicanna Inc
Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D and clinical development leading to the commercialization of more than thirty proprietary, evidence-based finished products and supporting four commercial stage business pillars.

• Medical Cannabis formulary (RHO Phyto™): The formulary offers a diverse range of proprietary products including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids, supported by ongoing patient and medical community education. RHO Phyto is an established brand in Canada currently available nationwide across several channels and expanding into new international markets.
• Medical cannabis care platform (MyMedi.ca): MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the medical cannabis patients’ journey. MyMedi.ca is operated by Northern Green Canada Inc. and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. MyMedi.ca also provides specialty services to distinct patient groups such as veterans and collaborates with public and private payers for adjudication and reimbursement. MyMedi.ca provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens.
• Pharmaceutical pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. These cannabinoid-based candidates aim to address unmet needs in the areas of dermatology, chronic pain, and various neurological disorders.
• Active pharmaceutical ingredients (Aureus Santa Marta™): Active pharmaceutical ingredients supplied by the Company’s majority owned subsidiary Santa Marta Golden Hemp SAS (“SMGH”) is a commercial-stage business dedicated to providing various forms of high-quality CBD, THC and CBG to the Company’s international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products. SMGH also forms part of the Company’s supply chain and is a source of reliable input products for its consumer retail, medical cannabis, and pharmaceutical products globally.

SOURCE Avicanna Inc. 

Stay Connected 
For more information about Avicanna, visit our website or contact Ivana Maric by email at ir@avicanna.com. 

Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this news release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions. Forward-looking information contained in this news release includes, without limitation, statements with respect to the Company’s future business operations, the opinions or beliefs of management and future business goals. Although the Company believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated March 31, 2026, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR+ at www.sedarplus.ca. The statements in this news release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Mt. Laurel Township, NJ, Oct. 29, 2026 (GLOBE NEWSWIRE) —  Leader’s Advantage Acquisition Corp. (the “Company”) a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced today that it closed the sale of an additional 650,000 units of the Company, pursuant to the partial exercise of the underwriter’s over-allotment option granted in connection with the Company’s initial public offering (together with the over-allotment closing, the “Offering”), at the price of $10.00 per unit, resulting in additional gross proceeds of approximately $6,500,000.

After giving effect to this partial exercise of the over-allotment option, the total number of units sold in the Offering increased to 15,650,000 units, resulting in total gross proceeds of $156,500,000, before deducting underwriting discounts and estimated offering expenses.

The Company’s units began trading on September 18, 2026 on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “LEDRU.” Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “LEDR” and “LEDRW,” respectively.

The Company’s primary focus will be completing a healthcare-focused business combination with an established business of scale along with first-in-class drug candidates with large addressable markets poised for continued growth, led by a highly regarded management team, that the Company’s management believes would benefit from financial, operational, strategic or managerial enhancement to maximize value.

The Company’s management team is led by Dr. Paritosh M. Chakrabarti, Chairman and Chief Executive Officer, Dr. Raj Chakrabarti, President, and Edward Krynski, Chief Financial Officer.

Clear Street LLC acted as lead book-running manager and D. Boral Capital LLC acted as bookrunner for the Offering. 

A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on September 17, 2026. The Offering was made only by means of a prospectus. Copies of the final prospectus relating to the Offering may be obtained from: Clear Street LLC, Attn: Syndicate Department, 150 Greenwich Street, 45th Floor, New York, NY 10007, or via email at ecm@clearstreet.io and D. Boral Capital LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022, or via email at dbccapitalmarkets@dboralcapital.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements 

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated use of the net proceeds from the Offering and the Company’s expectations regarding its ability to complete a business combination. No assurance can be given that the Company will ultimately complete a business combination transaction in the sector it is targeting, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Media Contact:

Paul Weiss
pweiss@pmc-group.com

SINGAPORE, Oct. 29, 2026 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (“Uni-Fuels” or the “Company”) (Nasdaq: UFG), a global provider of marine fuel solutions headquartered in Singapore, today announced that it will effect a share consolidation of its Class A ordinary shares of par value US$0.0001 each and Class B ordinary shares of par value US$0.0001 each at a ratio of 1-for-10, effective on November 3, 2026 (the “Share Consolidation”). The Company’s Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on November 3, 2026. Upon the market opening on November 3, 2026, the Company’s Class A ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol “UFG” with the new CUSIP number G92Y4F134.

Prior to the Share Consolidation, 9,815,000 Class A ordinary shares and 22,650,000 Class B ordinary shares are issued and outstanding. As a result of the Share Consolidation, every 10 shares (or part thereof) will be combined into one (1) share, with fractional shares rounded up to the next whole share, and approximately 981,500 Class A ordinary shares and 2,265,000 Class B ordinary shares will be issued and outstanding after the Share Consolidation. The Company is authorized to issue 500,000,000 number of shares, divided into two Classes consisting of: (i) 450,000,000 Class A ordinary shares of par value US$0.001 each and (ii) 50,000,000 Class B ordinary shares of par value US$0.001 each. All outstanding stock options, warrants and other rights to purchase the Company’s Class A ordinary shares will be adjusted proportionately as a result of the Share Consolidation.

Upon the effectuation of the Share Consolidation, shareholders holding shares through a bank, broker or other nominee will have their shares automatically adjusted to reflect the Share Consolidation. Beneficial holders may contact their bank, broker or nominee for more information. Please direct any questions to your broker or the Company’s transfer agent, VStock Transfer, LLC, by calling +1 (212) 828-8436.

About Uni-Fuels Holdings Limited

Uni-Fuels is a fast-growing global provider of marine fuel solutions with a growing presence across major shipping hubs, including Singapore, Seoul, Dubai, Shanghai, Limassol, and Bangkok. Established in 2021, Uni-Fuels has evolved into a dynamic, forward-thinking company delivering customer-centric, compliant, and reliable fuel solutions across global markets and time zones, supported by 24/7 operational support year-round. Backed by a globally integrated operating platform, experienced industry professionals, and an extensive global supply network, Uni-Fuels has built trusted partnerships with customers, supporting them in achieving their operational objectives and decarbonization goals amid the maritime industry’s ongoing energy transformation.

For more information, visit www.uni-fuels.com.

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should” “would,” “plan,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other performance metrics and projections of market opportunity. These statements are based on various assumptions, whether or not identified in this communication and on the current expectations of Uni-Fuels’ management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Uni-Fuels. Some important factors that could cause actual results to differ materially from those in any forward-looking statements could include changes in domestic and foreign business, market, financial, political and legal conditions.

If any of these risks materialize or Uni-Fuels’ assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Uni-Fuels does not presently know, or that Uni-Fuels currently believes are immaterial that could also cause actual results to differ from those contained in the forward- looking statements. In addition, forward-looking statements reflect Uni-Fuels’ current expectations, plans and forecasts of future events and views as of the date hereof. Nothing in this communication should be regarded as a representation by any person that the forward- looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein and the risk factors of Uni-Fuels described in its Form 20-F initially filed with the SEC, as amended, together with the risk factors of Uni-Fuels described in its prospectus supplement to the base prospectus filed with the SEC on October 23, 2026 in connection with its registration statement on Form F-3 (File No. 333-292786), including those under “Risk Factors” therein. Uni-Fuels anticipates that subsequent events and developments will cause its assessments to change. However, while Uni-Fuels may elect to update these forward-looking statements at some point in the future, Uni-Fuels specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Uni-Fuels’ assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Contact Information

For Investor Relations:

Uni-Fuels Holdings Limited

Email: investors@uni-fuels.com

MILWAUKEE, Oct. 29, 2026 (GLOBE NEWSWIRE) — Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for the first quarter ended September 30, 2026.

Net sales for the first quarter ended September 30, 2026 were $3,094,078, a decline of $976,700, or 24.0%, compared to net sales of $4,070,778 for the three months ended September 30, 2025. A net loss of $234,168 was generated for the three months ended September 30, 2026 compared to net income of $243,729 for the same period in the prior year. Basic and diluted net loss per common share for the first quarter of fiscal year 2027 was $0.02 compared to basic and diluted net income per common share of $0.03 for the same three-month period one year ago.

“Sales to certain domestic distributors were strong in the first quarter of fiscal year 2027 compared with the prior-year period. However, the significant custom order that shipped in the first quarter of last year for an Education customer’s new product launch did not recur this year. European distributor sales for the three months ended September 30, 2026 were on par to those for the same period in the prior year, supported by necessary inventory replenishment orders,” Michael J. Koss, Chairman and CEO, said today. “Direct-to-consumer (DTC) sales continue to positively impact sales growth and now represent approximately 37% of the Company’s total turnover.”

Koss continued, “The Company’s gross margin declined 50 basis points to 39.5% in the first quarter of fiscal 2027, compared with 40.0% a year earlier. The benefit to gross margins of a favorable customer mix of higher margin DTC and domestic distributor sales, along with the recognition of a final tariff refund of $76,000 for previously paid import duties on product from China, were negated by the impact of fixed manufacturing overhead absorption on a lower sales base, coupled with higher freight rates due to general rate increases and peak season surcharges.”

“We remain encouraged by the strength of our domestic distributor business and the growing contribution of DTC sales, which position the Company to build on these positive trends as the fiscal year progresses,” Koss concluded.

About Koss Corporation

Koss Corporation markets a complete line of high-fidelity headphones, wireless Bluetooth® speakers, computer headsets, telecommunications headsets, active noise canceling headphones, and wireless headphones. Learn more at koss.com and kosscorporation.com.

Forward-Looking Statements

This press release contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “may,” “will,” “should,” “could,” “would,” “shall,” “forecasts,” “predicts,” “potential,” “continue,” “seeks,” “goal,” “projects” or the negative of such terms and other comparable terminology. These statements are based on currently available operating, financial and competitive information and are subject to various risks and uncertainties. Actual events or results may differ materially. In evaluating forward-looking statements, you should specifically consider various factors that may cause actual results to vary from those contained in the forward-looking statements, such as continued future fluctuations in economic conditions; the Company’s ability to successfully develop new products and assess potential market opportunities; the receptivity of consumers to new consumer electronics technologies; the Company’s ability to successfully and profitably market its products; the rate and consumer acceptance of new product introductions; the amount and nature of competition for the Company’s products; pricing; the number and nature of customers and their product orders; the Company’s ability to meet demand for products; production by third party vendors; foreign manufacturing, sourcing, and sales (including foreign government regulation, trade and importation concerns); uncertainties associated with the pandemics and other health crises or natural disasters, including their possible effects on the Company’s operations and its supply chain; changes in trade policies and tariffs, import and export restrictions; the impact of the ongoing conflict in Eastern Europe and the instability and escalation in the Middle East on the Company’s operations; the effects of any judicial, executive or legislative action affecting the Company or the audio/video industry; borrowing costs; changes in tax rates; volatility in the price and trading volume of our common stock; the outcome of any litigation, government investigations, enforcement actions or other legal proceedings; any impacts of future acquisitions or other strategic transactions; the possibility that costs or difficulties related to the integration of acquired businesses’ operations will be greater than expected and the possibility that integration efforts will disrupt our business and strain management time and resources; the Company’s ability to retain and hire key personnel and other risk factors described in the Risk Factors and Management’s Discussion and Analysis of Financial Condition and Results of Operations sections in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2026. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances or new information. In addition, such uncertainties and other operational matters are discussed further in the Company’s quarterly and annual filings with the Securities and Exchange Commission.

KOSS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
	Three Months Ended
	September 30
	2026				2025
Net sales	$	3,094,078			$	4,070,778
Cost of goods sold		1,872,243				2,442,086
Gross profit		1,221,835				1,628,692
Selling, general and administrative expenses		1,622,430				1,674,732
Loss from operations		(400,595	)			(46,040	)
Other income (expense):
Interest income		169,070				293,128
Interest expense		(409	)			(599	)
Total other income, net		168,661				292,529
(Loss) income before income tax provision		(231,934	)			246,489
Income tax provision		2,234				2,760
Net (loss) income	$	(234,168	)		$	243,729
(Loss) income per common share:
Basic	$	(0.02	)		$	0.03
Diluted	$	(0.02	)		$	0.03
Weighted-average number of shares:
Basic		9,466,438				9,456,438
Diluted		9,466,438				9,537,817

CONTACT:	Michael J. Koss
	Chairman & CEO
	(414) 964-5000
	mjkoss@koss.com

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) announced today that Prospect priced an institutional offering of $300 million in aggregate principal amount of senior unsecured 8.95% Notes due 2031 (the “Notes”).

“We appreciate the support we received for this unsecured bond offering,” said Grier Eliasek, President of Prospect. “This leverage neutral bond offering further strengthens our already diversified financing sources as we continue to ladder our maturity schedule.”

The Notes will bear interest at a rate of 8.95% per annum payable semi-annually in arrears on April 30 and October 31 of each year, commencing on April 30, 2027.

The Notes will be general senior unsecured obligations of Prospect and will rank equally in right of payment with Prospect’s existing and future senior unsecured debt.

The Notes will mature on October 31, 2031 and may be redeemed, at our option, in whole or in part at any time or from time to time, at certain specified redemption prices. The offering is expected to close on November 5, 2026, subject to customary closing conditions.

Prospect expects to use the net proceeds of this offering for the refinancing of existing indebtedness, including its existing 3.364% unsecured notes due 2026 and/or borrowings under its revolving credit facility, and, if there are any remaining net proceeds, for general corporate purposes, including investments and balance sheet liquidity.

The offering of the Notes was made only by means of a prospectus supplement and the accompanying prospectus. This announcement does not constitute an offer to sell or a solicitation of an offer to buy any of the Notes, nor shall there be any offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

About Prospect Capital Corporation

Prospect is a business development company that primarily lends to and invests in middle market privately-held companies. Prospect’s investment objective is to generate both current income and long-term capital appreciation.

Prospect has elected to be treated as a business development company under the Investment Company Act of 1940. Prospect has elected to be treated as a regulated investment company under the Internal Revenue Code of 1986.

Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, whose safe harbor for forward-looking statements does not apply to business development companies. Any such statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that we may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements. Such statements speak only as of the time when made, and we undertake no obligation to update any such statement now or in the future.

For additional information, contact:

Grier Eliasek, President and Chief Operating Officer
grier@prospectcap.com
Telephone (212) 448-0702

SINGAPORE, Oct. 29, 2026 (GLOBE NEWSWIRE) — Fitness Champs Holdings Limited (“Fitness Champs Holdings”, “FCHL” or the “Company”) (NASDAQ: FCHL), a distinguished aquatic sports education provider in Singapore, will hold an Annual General Meeting of Shareholders (the “AGM”) at 55 Serangoon North Avenue 4, #01-05, Singapore 555859 at 10am (Singapore Time) on November 12, 2026 (9pm Eastern Time on November 11, 2026).

Holders of the Company’s class A ordinary shares (the “Class A Ordinary Shares”) and class B ordinary shares (the “Class B Ordinary Shares”) and, together with the Class A Ordinary Shares, the “Ordinary Shares”) listed in the register of members of the Company at the close of business on October 22, 2026 (Singapore Time) are entitled to receive notice of, and vote at, the AGM or at any adjournment or postponement that may take place.

Copies of the Notice of the AGM, which sets forth the resolutions to be proposed and for which adoption from shareholders is sought, the Proxy Statement and the Proxy Card are available on the Investor Relations section of the Company’s website at https://ir.fitnesschamps.sg and on the SEC’s website at www.sec.gov.

About Fitness Champs Holdings Limited

Fitness Champs Holdings Limited is a distinguished aquatic sports education provider, offering general swimming lessons to children and adults, with ladies-only swimming lessons available, as well as aquatic sports classes such as water polo, competitive swimming and lifesaving. The Company is one of the largest providers of swimming lessons to children enrolled in public schools under the Ministry of Education of Singapore in Singapore through the SwimSafer program, and has been offering private swimming lessons to children, youths and adults under its brand “Fitness Champs” since 2012. The Company aims to make swimming an enjoyable and affordable sport for children and adults, for water safety and as a way of keeping fit and healthy. Fitness Champs also plans to grow into a diversified sports education provider by expanding its offerings to include other sports such as pickleball. For more information, please visit the Company’s website at https://ir.fitnesschamps.sg/.

For investor and media inquiries, please contact:

Email: ir@fitnesschampsaquatics.com

Except where otherwise noted, all currency amounts are stated in United States dollars.

Financial and Production Highlights

• Net income attributable to Methanex shareholders of $265 million, Adjusted EBITDA of $543 million, and Adjusted net income of $284 million in the third quarter.
• Reported an average realized price in the third quarter of $510 per tonne compared to $529 per tonne in the second quarter of 2026. Based on our October and November posted prices and current spot pricing, we expect that our average realized price range will be approximately $525 to $550 per tonne for these two months.
• Produced 2,143,000 tonnes of methanol in the third quarter, with record North American production.
• Announced an agreement to sell substantially all of our remaining New Zealand natural gas contractual entitlements commencing in the first quarter of 2027 and continuing through the end of the decade when such entitlements expire. The expected indefinite idling of our New Zealand production facilities during the first quarter of 2027 resulted in a $10 million accrual for restructuring activities, which has been included as a deduction in the calculation of Adjusted EBITDA.
• Generated $646 million of cash flows from operating activities, returned $14 million to shareholders through regular dividends and ended the quarter with $912 million in cash. Provided notice to redeem $300 million of our existing $700 million bonds due in October 2027 and expect to redeem the final $400 million during the fourth quarter of 2026.
• Subsequent to the quarter, announced approval of a 5% normal course issuer bid to repurchase up to 3,868,213 common shares through November 3, 2027.

VANCOUVER, British Columbia, Oct. 29, 2026 (GLOBE NEWSWIRE) — For the third quarter of 2026, Methanex (TSX:MX) (NASDAQ:MEOH) reported net income attributable to Methanex shareholders of $265 million ($3.42 net income per common share on a diluted basis) compared to a net income of $198 million ($2.45 net income per common share on a diluted basis) in the second quarter of 2026. Adjusted EBITDA for the third quarter of 2026 was $543 million and Adjusted net income was $284 million ($3.69 Adjusted net income per common share). This compares with Adjusted EBITDA of $577 million and Adjusted net income of $300 million ($3.87 Adjusted net income per common share) for the second quarter of 2026.

Rich Sumner, President & CEO of Methanex, said, “The Middle East conflict’s dramatic impact on the methanol industry persisted through the third quarter, with the significant loss of industry supply supporting ongoing pricing strength. Our enhanced asset base continued to run well, particularly in North America, helping to drive another quarter of strong Adjusted EBITDA and cash flow. We remain focused on operating our assets and supply chain safely and reliably as we continue to navigate dynamic conditions.”

FURTHER INFORMATION

The information set forth in this news release summarizes Methanex’s key financial and operational data for the third quarter of 2026. It is not a complete source of information for readers and is not in any way a substitute for reading the third quarter 2026 Management’s Discussion and Analysis (“MD&A”) dated October 29, 2026 and the unaudited condensed consolidated interim financial statements for the period ended September 30, 2026, both of which are available from the Investor Relations section of our website at www.methanex.com. The MD&A and the unaudited condensed consolidated interim financial statements for the period ended September 30, 2026 are also available on the Canadian Securities Administrators’ SEDAR+ website at www.sedarplus.ca and on the United States Securities and Exchange Commission’s EDGAR website at www.sec.gov.

FINANCIAL AND OPERATIONAL DATA

	Three Months Ended					Nine Months Ended
($ millions except per share amounts and where noted)	Sep 30 2026	Jun 30 2026	Sep 30 2025			Sep 30 2026	Sep 30 2025
Production (thousands of tonnes) (attributable to Methanex shareholders)1	2,143	2,213	2,212			6,747	5,452
Sales volume (thousands of tonnes)
Methanex-produced methanol	2,279	2,151	1,891			6,656	5,122
Purchased methanol	170	247	488			639	1,321
Commission sales	146	157	97			477	383
Total methanol sales volume	2,595	2,555	2,476			7,772	6,826
Methanex average non-discounted posted price ($ per tonne)2	987	1,007	578			866	606
Average realized price ($ per tonne)3	510	529	345			462	373
Revenue4	1,388	1,395	927			3,756	2,620
Net income (loss) (attributable to Methanex shareholders)	265	198	(7	)		449	169
Adjusted net income5	284	300	5			608	159
Adjusted EBITDA5	543	577	191			1,340	622
Cash flows from operating activities	646	439	184			1,217	776
Adjusted free cash flow5	520	298	85			848	425
Basic net income (loss) per common share	3.43	2.56	(0.09	)		5.81	2.38
Diluted net income (loss) per common share	3.42	2.45	(0.09	)		5.81	2.21
Adjusted net income per common share5	3.69	3.87	0.06			7.90	2.23
Common share information (millions of shares)
Weighted average number of common shares	77	77	77			77	71
Diluted weighted average number of common shares	77	78	77			77	71
Number of common shares outstanding, end of period	77	77	77			77	77
Methanex-produced methanol represents our equity share of methanol volume produced at our facilities and excludes volume marketed on a commission basis related to the 50% of the Egypt facility that we do not own. Methanex average non-discounted posted price represents the average of our non-discounted posted prices in North America, Europe, China and Asia Pacific weighted by total methanol sales volume. Current and historical pricing information is available at www.methanex.com. The Company has used Average realized price (“ARP”) throughout this document. ARP is calculated as methanol revenue divided by the total methanol sales volume. It is used by management to assess the realized price per unit of methanol sold, and is relevant in a cyclical commodity environment where revenue can fluctuate in response to market prices. Revenue includes sales of ammonia and other products, in addition to sales of methanol. Note that Adjusted net income, Adjusted net income per common share, Adjusted EBITDA, and Adjusted free cash flow are non-GAAP measures and ratios that do not have any standardized meaning prescribed by GAAP and therefore are unlikely to be comparable to similar measures presented by other companies. Refer to the Additional Information –Non-GAAP Measures section on page 14 of our third quarter MD&A dated October 29, 2026 for a description of each non-GAAP measure.

• A reconciliation from net income attributable to Methanex shareholders to Adjusted EBITDA, Adjusted net income and the calculation of Adjusted net income per common share is as follows:

	Three Months Ended										Nine Months Ended
($ millions)	Sep 30 2026			Jun 30 2026			Sep 30 2025				Sep 30 2026			Sep 30 2025
Net income (loss) attributable to Methanex shareholders	$	265		$	198		$	(7	)		$	449		$	169
Mark-to-market impact of share-based compensation		36			(22	)		13				59			(26	)
Depreciation and amortization		117			121			111				357			319
Finance costs		49			54			61				158			163
Finance income and other expenses		(17	)		15			(3	)			2			(16	)
Income tax expense		96			104			4				203			43
Asset impairment charge1		—			100			—				100			—
Earnings of associates adjustment		27			33			34				95			41
Non-controlling interests adjustment		(30	)		(26	)		(22	)			(83	)		(71	)
Adjusted EBITDA	$	543		$	577		$	191			$	1,340		$	622

	Three Months Ended										Nine Months Ended
($ millions except number of shares and per share amounts)	Sep 30 2026			Jun 30 2026			Sep 30 2025				Sep 30 2026			Sep 30 2025
Net income (loss) attributable to Methanex shareholders	$	265		$	198		$	(7	)		$	449		$	169
Mark-to-market impact of share-based compensation, net of tax		28			(17	)		11				48			(19	)
Mark-to-market impact of gas contract revaluations, net of tax		(9	)		4			1				(3	)		9
Asset impairment charge, net of tax1		—			115			—				115			—
Earnings of associates adjustment, net of tax		—			—			—				(1	)		—
Adjusted net income	$	284		$	300		$	5			$	608		$	159
Diluted weighted average shares outstanding (millions)		77			78			77				77			71
Adjusted net income per common share	$	3.69		$	3.87		$	0.06			$	7.90		$	2.23
The asset impairment charge includes $26 million ($33 million, net of tax) relating to the Titan facility and the Company’s 63.1% share of the impairment charge recognized by Atlas of $74 million ($82 million, net of tax).

• We recorded net income attributable to Methanex shareholders of $265 million in the third quarter of 2026 compared to net income of $198 million in the second quarter of 2026. Net income in the third quarter of 2026 was higher compared to the prior quarter primarily due to the impact of the asset impairment charge recorded in the second quarter of 2026. This was partially offset by a lower average realized price in the third quarter of 2026.
• We sold 2,595,000 tonnes of methanol in the third quarter of 2026 compared to 2,555,000 tonnes of methanol in the second quarter of 2026. Sales of Methanex-produced methanol were 2,279,000 tonnes in the third quarter of 2026 compared to 2,151,000 tonnes in the second quarter of 2026.
• Production of methanol for the third quarter of 2026 was 2,143,000 tonnes compared to 2,213,000 tonnes for the second quarter of 2026. Production was strong across our North American and Egypt assets and was lower in Chile, where we experienced expected seasonal gas availability constraints. In Trinidad, production declined as the Titan plant ceased operations and was indefinitely idled.
• We announced an agreement to sell substantially all of our remaining New Zealand natural gas contractual entitlements commencing in the first quarter of 2027 and continuing through the end of the decade when such entitlements expire. The expected indefinite idling of our New Zealand production facilities during the first quarter of 2027 resulted in a $10 million accrual for restructuring activities, which has been included as a deduction in the calculation of Adjusted EBITDA.
• In the third quarter of 2026 we paid a quarterly dividend of $0.185 per common share for a total of $14 million.
• At September 30, 2026, we had a strong liquidity position, including a cash balance of $912 million and access to a $400 million unutilized revolving credit facility. The Company provided notice to redeem $300 million of our existing $700 million bonds originally due in October 2027. The amount was repaid subsequent to the quarter.
• Subsequent to the quarter, on October 29, 2026, we announced approval of a 5% normal course issuer bid to repurchase up to 3,868,213 common shares through November 3, 2027.

 PRODUCTION HIGHLIGHTS

	Q3 2026		Q2 2026	Q3 2025	YTD Q3 2026	YTD Q3 2025
(thousands of tonnes)	Operating Capacity1	Production	Production	Production	Production	Production
USA
Geismar	1,000	1,007	1,027	931	2,968	2,377
Beaumont2	228	199	185	239	579	250
Natgasoline (50% interest)2	213	221	204	222	628	232
Canada (Medicine Hat)	140	140	143	140	407	363
Chile	425	221	322	224	941	948
Egypt (50% interest)	158	165	165	130	494	390
New Zealand3	215	156	46	123	360	336
Trinidad4	215	34	121	203	370	556
Total Methanol Production	2,594	2,143	2,213	2,212	6,747	5,452
Beaumont Ammonia2	85	83	83	88	251	92
The operating capacity of our production facilities may be higher or lower than original nameplate capacity as, over time, these figures have been adjusted to reflect ongoing operating efficiencies at these facilities. Actual production for a facility in any given year may be higher or lower than operating capacity due to a number of factors, including natural gas availability, feedstock composition, the age of the facility’s catalyst, turnarounds and access to CO2from external suppliers for certain facilities. We review and update the operating capacity of our production facilities on a regular basis based on historical performance. The facilities were acquired on June 27, 2025. The operating capacity of New Zealand consists of one Motunui facility, with the other excluded as it is currently idle. The Company expects to indefinitely idle the remaining Motunui facility during the first quarter of 2027. Refer to the New Zealand section below. The operating capacity of Trinidad consists of the Titan facility (100% interest). The Atlas facility (63.1% interest) is excluded as it is currently idle. The Company indefinitely idled the Titan facility during the third quarter. Refer to the Trinidad section below.

Key production and operational highlights during the third quarter include:

United States

Geismar produced 1,007,000 tonnes in the third quarter of 2026 compared to 1,027,000 tonnes in the second quarter of 2026. Beaumont produced 199,000 tonnes of methanol and 83,000 tonnes of ammonia in the third quarter of 2026 compared to 185,000 tonnes of methanol and 83,000 tonnes of ammonia in the second quarter of 2026. Beaumont’s methanol production was higher as the plant was offline for approximately 30 days starting in early June to repair the cooling tower. The Natgasoline plant produced 221,000 tonnes of methanol (Methanex share) in the third quarter of 2026 compared to 204,000 tonnes of methanol (Methanex share) in the second quarter of 2026.

Canada

Medicine Hat produced 140,000 tonnes in the third quarter of 2026 compared to 143,000 tonnes in the second quarter of 2026.

Chile

Chile produced 221,000 tonnes in the third quarter of 2026 compared to 322,000 tonnes in the second quarter of 2026. Production was lower in the third quarter compared to the second quarter as we undertook a single-plant operation through most of the period due to the seasonal reduction of gas availability from Argentina. We restarted two-plant operations late in September. We have gas contracts in place with Chilean and Argentinean gas producers until 2030 and 2027, respectively, which underpin approximately 55% of the site’s gas requirements year-round. While seasonality in production is expected to continue, we are seeing generally positive developments in natural gas availability to supply our Chile facilities.

Egypt

Egypt produced 330,000 tonnes (Methanex interest – 165,000 tonnes) in the third quarter of 2026 compared to 330,000 tonnes (Methanex interest – 165,000 tonnes) in the second quarter of 2026. Gas availability in Egypt is influenced by several factors, including domestic production levels, gas imports and seasonal demand fluctuations. We are monitoring the gas market closely and we may experience curtailments in the future, particularly in the summer months, depending on gas supply and demand dynamics in the domestic and international markets.

New Zealand

New Zealand produced 156,000 tonnes in the third quarter of 2026 compared to 46,000 tonnes in the second quarter of 2026. Production was higher in the third quarter due to a planned winter outage in the second quarter to supply gas to the New Zealand electricity sector. The plant was restarted in July and continues to operate at reduced rates. We announced an agreement to sell substantially all of our remaining New Zealand natural gas contractual entitlements commencing in the first quarter of 2027 and continuing through the end of the decade when such entitlements expire, and the expected indefinite idling of the New Zealand production facilities during the first quarter of 2027.

Trinidad

In Trinidad, the Titan plant produced 34,000 tonnes in the third quarter of 2026 compared to 121,000 tonnes in the second quarter of 2026. Production was lower in the third quarter as the plant ceased operations and was indefinitely idled.

Outlook

We expect our 2026 production to be approximately 9.0 million tonnes (Methanex interest) of methanol and 0.3 million tonnes of ammonia. Actual production may vary by quarter based on gas availability, turnarounds, unplanned outages and unanticipated events.

Based on our October and November posted prices and current spot pricing, we expect that our average realized price range will be approximately $525 to $550 per tonne for these two months. Based on a higher realized price and similar sales of produced methanol, we are expecting higher Adjusted EBITDA in the fourth quarter.

CONFERENCE CALL

A conference call is scheduled for October 30, 2026 at 11:00 am ET (8:00 am PT) to review these third quarter results. To access the call, dial the conferencing operator fifteen minutes prior to the start of the call at (585) 542-9983, or toll free at (833) 461-5787. The conference ID for the call is #421166240. A simultaneous audio-only webcast of the conference call can be accessed from our website at www.methanex.com/investor-relations/events and will also be available following the call.

ABOUT METHANEX

Methanex is a Vancouver-based, publicly traded company and is the world’s largest producer and supplier of methanol to customers globally. Methanex shares are listed for trading on the Toronto Stock Exchange in Canada under the trading symbol “MX” and on the Nasdaq Global Market in the United States under the trading symbol “MEOH”.

FORWARD-LOOKING INFORMATION WARNING

This third quarter 2026 press release contains forward-looking statements with respect to us and the chemical industry. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond the Company’s control. Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Methanex does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law. Refer to Forward-Looking Information Warning in the third quarter 2026 Management’s Discussion and Analysis for more information which is available from the Investor Relations section of our website at www.methanex.com, the Canadian Securities Administrators’ SEDAR+ website at www.sedarplus.ca and on the United States Securities and Exchange Commission’s EDGAR website at www.sec.gov.

NON-GAAP MEASURES

Throughout this document, the Company has used the terms Adjusted EBITDA, Adjusted net income, Adjusted net income per common share, and Adjusted Free Cash Flow. These items are non-GAAP measures and ratios that do not have any standardized meaning prescribed by GAAP. These measures represent the amounts that are attributable to Methanex Corporation shareholders and are calculated by excluding the mark-to-market impact of share-based compensation as a result of changes in our share price, the impact of gas and other contract revaluations and the impact of certain items associated with specific identified events. Refer to Additional Information – Non-GAAP Measures on page 14 of the Company’s MD&A for the period ended September 30, 2026 for reconciliations to the most comparable GAAP measures. Unless otherwise indicated, the financial information presented in this release is prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

For further information, contact:
Robert B. Winslow, CFA
Vice President, Investor Relations
Methanex Corporation
604-661-2600